Threshold Pharmaceuticals’ stock plunges after drug trial disappoints
December 07, 2015 at 07:29 AM EST
Theshold Pharmaceutical’s stock plunges toward the lowest price since July 2010 after two late-stage trials of its cancer treatment failed to meet their primary endpoint.
